Alliance forms to accelerate adoption of decentralized clinical trials
Share The Decentralized Trials and Research Alliance (DTRA) recently launched to accelerate the broad adoption of patient-focused decentralized clinical trials and research. It plans to unite stakeholders across the health spectrum to further policies, research practices and technology innovation for decentralized clinical trials. The alliance is currently made up of more than 50 life sciences and healthcare organizations, including AstraZeneca, the U.S. Food and Drug Administration, Pfize...
Amir Kalali Wolters Kluwer Public Health Emergency Collection Drug Administration Research Alliance Decentralized Trials Wolters Kluwer Public Health Emergency
Source: mobihealthnews.com